Definium Therapeutics, Inc. (DFTX) Stock Forecast 2026: P10, P50 & P90 — Probabli.AI
Timestamped DFTX stock forecast with 1-year P10, P50, and P90 price estimates, scenario probabilities, definitions, sources, and limitations.
Direct answer: Definium Therapeutics, Inc. (DFTX) is positioned for substantial short-term growth with promising phase 3 trial results, a significant collaboration with a pharma giant, and a strong 'strong buy' analyst consensus pointing towards potential stock appreciation. Despite facing challenges like earnings surprises and patent disputes, its innovative drug pipeline and strategic partnerships create multiple growth opportunities. While volatility from patent litigation and cash flow issues present risks, the overall outlook remains bullish, with considerable upside potential over both the short and long term. The saved 1-year distribution is P10 $28, P50 $55, and P90 $70.
Last analyzed · Model: gpt-4o
Definium Therapeutics, Inc. Forecast data
| Estimate | 1-year price | Meaning |
|---|
| P10 | $28 | Pessimistic plausible scenario |
| P50 | $55 | Median scenario |
| P90 | $70 | Optimistic plausible scenario |
What the numbers mean
P10, P50, and P90 are model-generated scenario estimates: roughly a pessimistic plausible outcome, a median outcome, and an optimistic plausible outcome. They are not calibrated confidence intervals.
Supporting analysis
Definium Therapeutics has shown potential for rapid short-term appreciation due to significant positive news, including promising phase 3 results and a major collaboration deal. Despite a history of missing earnings expectations, the recent favorable coverage from analysts and a strong buy consensus suggest immediate upside potential. However, uncertainties around patent challenges and cash flow stability present risks.
Sources and limitations
Market and company inputs are primarily sourced through Yahoo Finance and public financial-data interfaces. This page reports a saved AI-generated scenario analysis as of the timestamp above; it is not live data, audited probability, financial advice, or a guaranteed return.
Frequently asked questions
When was this DFTX analysis generated?
June 24, 2026.
Is this a guaranteed DFTX prediction?
No. It is a model-generated scenario assessment with material uncertainty.
View the full DFTX stock analysis · DFTX sentiment · Methodology · Accuracy & validation
The information on this page is for educational and informational purposes only and does not constitute professional financial advice.